Health Condition 1: G318- Other specified degenerative diseases of nervous system
Conditions
Interventions
None listed
Sponsors
Institute of Teaching and Research in Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects irrespective of gender, fulfilling the criteria of Mild Neurocognitive Disorder as per DSM V. 2) Age group – 40 - 70 years 3) Montreal Cognitive Assessment scale [MoCA] (18 to 25) 4) Patients willing to accept participation in the clinical trial.
Exclusion criteria
Exclusion criteria: 1) Age below 40 years and above 70 years. 2) Subjects with major depression or other psychiatric disorders or currently undergoing treatment for depression. 3) Use of psychoactive medication that would affect the subject’s ability to reliably perform on neurocognitive testing. 4) Subjects with Malignant disease, HIV or serious infection. 5) Subjects with Cardiovascular, Renal or Hepatic disorder, Thyroid dysfunction. 6)subjects with Stage II HTN or above (Blood Pressure >160/100 mm of Hg), Diabetes (FBS >200 mg/dl), Dyslipidemia (Severe Hypertriglyceridemia,TG >500 mg/dl and /or, LDL >190 mg/dl) 7) Subjects who have decline in cognitive functions as a result of surgery and trauma. 8) Visual/auditory impairment that would preclude the participant from participating in or cooperating with the protocol. 9) Pregnant women and lactating mothers. 10) Patient with alcohol abuse. 11) Subjects who are not able to read, write and comprehend Hindi language properly for comprehending the assessment tests.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in cognitionTimepoint: At baseline ,4th week , 8th week , 10th week , 12 th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of quality of life of the patients with mild Neurocognitive DisorderTimepoint: Baseline and 8th week | — |
Countries
India
Contacts
Public ContactDr Mandip Goyal
Institute of Teaching and Research in Ayurveda, Gujarat, Jamnagar – 361008
Outcome results
None listed